28193238|t|Transient IKK2 activation in astrocytes initiates selective non-cell-autonomous neurodegeneration.
28193238|a|BACKGROUND: Neuroinflammation is associated with a wide range of neurodegenerative disorders, however the specific contribution to individual disease pathogenesis and selective neuronal cell death is not well understood. Inflammatory cerebellar ataxias are neurodegenerative diseases occurring in various autoimmune/inflammatory conditions, e.g. paraneoplastic syndromes. However, how inflammatory insults can cause selective cerebellar neurodegeneration in the context of these diseases remains open, and appropriate animal models are lacking. A key regulator of neuroinflammatory processes is the NF-kappaB signalling pathway, which is activated by the IkappaB kinase 2 (IKK2) in response to various pathological conditions. Importantly, its activation is sufficient to initiate neuroinflammation on its own. METHODS: To investigate the contribution of IKK/NF-kappaB-mediated neuroinflammation to neurodegeneration, we established conditional mouse models of cerebellar neuroinflammation, which depend either on the tetracycline-regulated expression of IKK2 in astrocytes or Cre-recombination based IKK2 activation in Bergmann glia. RESULTS: We demonstrate that IKK2 activation for a limited time interval in astrocytes is sufficient to induce neuroinflammation, astrogliosis and loss of Purkinje neurons, resembling the pathogenesis of inflammatory cerebellar ataxias. We identified IKK2-driven irreversible dysfunction of Bergmann glia as critical pathogenic event resulting in Purkinje cell loss. This was independent of Lipocalin 2, an acute phase protein secreted by reactive astrocytes and well known to mediate neurotoxicity. Instead, downregulation of the glutamate transporters EAAT1 and EAAT2 and ultrastructural alterations suggest an excitotoxic mechanism of Purkinje cell degeneration. CONCLUSIONS: Our results suggest a novel pathogenic mechanism how diverse inflammatory insults can cause inflammation/autoimmune-associated cerebellar ataxias. Disease-mediated elevation of danger signals like TLR ligands and inflammatory cytokines in the cerebellum activates IKK2/NF-kappaB signalling in astrocytes, which as a consequence triggers astrogliosis-like activation of Bergmann glia and subsequent non-cell-autonomous Purkinje cell degeneration. Notably, the identified hit and run mechanism indicates only an early window for therapeutic interventions.
28193238	10	14	IKK2	Gene	16150
28193238	80	97	neurodegeneration	Disease	MESH:D019636
28193238	111	128	Neuroinflammation	Disease	MESH:D000090862
28193238	164	191	neurodegenerative disorders	Disease	MESH:D019636
28193238	320	351	Inflammatory cerebellar ataxias	Disease	MESH:D002524
28193238	356	382	neurodegenerative diseases	Disease	MESH:D019636
28193238	415	427	inflammatory	Disease	MESH:D007249
28193238	445	469	paraneoplastic syndromes	Disease	MESH:D010257
28193238	484	496	inflammatory	Disease	MESH:D007249
28193238	525	553	cerebellar neurodegeneration	Disease	MESH:D002526
28193238	663	680	neuroinflammatory	Disease	MESH:D000090862
28193238	698	707	NF-kappaB	Gene	18033
28193238	754	770	IkappaB kinase 2	Gene	16150
28193238	772	776	IKK2	Gene	16150
28193238	880	897	neuroinflammation	Disease	MESH:D000090862
28193238	958	967	NF-kappaB	Gene	18033
28193238	977	994	neuroinflammation	Disease	MESH:D000090862
28193238	998	1015	neurodegeneration	Disease	MESH:D019636
28193238	1044	1049	mouse	Species	10090
28193238	1071	1088	neuroinflammation	Disease	MESH:D000090862
28193238	1117	1129	tetracycline	Chemical	MESH:D013752
28193238	1154	1158	IKK2	Gene	16150
28193238	1200	1204	IKK2	Gene	16150
28193238	1263	1267	IKK2	Gene	16150
28193238	1345	1362	neuroinflammation	Disease	MESH:D000090862
28193238	1364	1376	astrogliosis	Disease	MESH:D005911
28193238	1438	1469	inflammatory cerebellar ataxias	Disease	MESH:D002524
28193238	1485	1489	IKK2	Gene	16150
28193238	1625	1636	Lipocalin 2	Gene	16819
28193238	1719	1732	neurotoxicity	Disease	MESH:D020258
28193238	1788	1793	EAAT1	Gene	20512
28193238	1798	1803	EAAT2	Gene	20511
28193238	1847	1858	excitotoxic	Disease	
28193238	1872	1898	Purkinje cell degeneration	Disease	MESH:D002292
28193238	1974	1986	inflammatory	Disease	MESH:D007249
28193238	2005	2017	inflammation	Disease	MESH:D007249
28193238	2040	2058	cerebellar ataxias	Disease	MESH:D002524
28193238	2126	2148	inflammatory cytokines	Disease	MESH:D000080424
28193238	2177	2181	IKK2	Gene	16150
28193238	2182	2191	NF-kappaB	Gene	18033
28193238	2250	2262	astrogliosis	Disease	MESH:D005911
28193238	2331	2357	Purkinje cell degeneration	Disease	MESH:D002292
28193238	Association	MESH:D002292	20511
28193238	Association	MESH:D002524	16150
28193238	Association	MESH:D000090862	16150
28193238	Association	MESH:D002292	18033
28193238	Positive_Correlation	16150	18033
28193238	Association	MESH:D013752	16150
28193238	Association	MESH:D002292	16150
28193238	Positive_Correlation	MESH:D000080424	18033
28193238	Association	MESH:D020258	16819
28193238	Association	MESH:D000080424	16150
28193238	Association	MESH:D002292	20512
28193238	Association	MESH:D005911	18033
28193238	Association	MESH:D019636	16150
28193238	Association	MESH:D005911	16150
28193238	Association	MESH:D000090862	18033
28193238	Association	MESH:D007249	16150

